Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 624, January 15, 2008. doi: 10.1158/0008-5472.CAN-07-5706
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bai, R.-K.
Right arrow Articles by Liu, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bai, R.-K.
Right arrow Articles by Liu, A.
Related Collections
Right arrowRelated Article

Letters to the Editor

Ren-Kui Bai, Suzanne M. Leal, Daniel Covarrubias and Lee-Jun C. Wong

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas

Daniel Covarrubias

Department of Statistics, Rice University, Houston, Texas

Aiyi Liu

Biometry and Mathematical Statistics Branch, National Institute of Child Health and Human Development, NIH, Rockville, Maryland

In Response: We recently reported that European-American females with haplogroup K mitochondrial DNA (mtDNA) variants have a significant increase in the risk of developing breast cancer, whereas women bearing haplogroup U have a decreased breast cancer risk (1). Mosquera-Miguel et al. studied sporadic breast cancer patients from continental Spain and the Canary Islands and found no evidence of an association for any mtDNA variants with breast cancer (CAN-07-5706). First, all cases in our study (1) have a family history of breast cancer; therefore, the study populations are not equivalent. Our own unpublished data also suggests that mtDNA variants associated with familial breast cancer risk may not be related to sporadic breast cancer.

The mtDNA haplogroup classification used in our study is based on previously published articles (refs. 25; Table 1 ). Haplogroup U is distinguished from haplogroup K by 9055G>A; both haplogroups U and K contain 12308G. To date, there is no widely accepted standard for the classification of haplogroups U and K. Although haplogroup K is a subclade of haplogroup U in Europeans, most, if not all, published articles on haplogroups and disease association do not include haplogroup K within haplogroup U.


View this table:
[in this window]
[in a new window]

 
Table 1. Classification of haplogroups U and K in the published references

 
Our study has yet to be replicated in an independent population and therefore some of the results could be false positives (type I error). Additionally, spurious findings could have been obtained because population admixture was not controlled for beyond limiting our case and control population to non-Jewish and non-Hispanic European-American women. Although some of the results published are novel, we replicated the finding that 10398A/G plays a role in breast cancer risk. Additional studies will be necessary to establish the role that mtDNA variants and haplogroups play in the etiology of breast cancer.

References

  1. Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. Mitochondrial genetic background modifies breast cancer risk. Cancer Res 2007;67:4687–94.[Abstract/Free Full Text]
  2. Herrnstadt C, Elson JL, Fahy E, et al. Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet 2002;70:1152–71.[CrossRef][Medline]
  3. Macaulay V, Richards M, Hickey E, et al. The emerging tree of West Eurasian mtDNAs: a synthesis of control-region sequences and RFLPs. Am J Hum Genet 1999;64:232–49.[CrossRef][Medline]
  4. Torroni A, Huoponen K, Francalacci P, et al. Classification of European mtDNAs from an analysis of three European populations. Genetics 1996;144:1835–50.[Abstract]
  5. van der Walt JM, Nicodemus KK, Martin ER, et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 2003;72:804–11.[CrossRef][Medline]

Related Article

Mitochondrial Genetic Background Modifies Breast Cancer Risk
Ren-Kui Bai, Suzanne M. Leal, Daniel Covarrubias, Aiyi Liu, and Lee-Jun C. Wong
Cancer Res. 2007 67: 4687-4694. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bai, R.-K.
Right arrow Articles by Liu, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bai, R.-K.
Right arrow Articles by Liu, A.
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online